Novartis says new products accounted for 21% of sales in Q2

Thursday 15 July 2010

Novartis AG said that recently launched products accounted for 21% of its second quarter sales and will more than offset the anticipated loss of sales from products going off patent in the next few years.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Switzerland